SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2zt9'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C8L_A_CFFA940_1 (PROTEIN (GLYCOGEN PHOSPHORYLASE))	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.00A	1c8lA-2zt9A: undetectable	1c8lA-2zt9A: 13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DVT_A_FLPA125_1 (TRANSTHYRETIN)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	4 / 8	LEU B 149 LEU B 96 LEU B 91 SER B 90	None	0.98A	1dvtA-2zt9B: undetectable 1dvtB-2zt9B: undetectable	1dvtA-2zt9B: 23.31 1dvtB-2zt9B: 23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.01A	1gfzA-2zt9A: undetectable	1gfzA-2zt9A: 13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.04A	1l5qA-2zt9A: undetectable	1l5qA-2zt9A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.03A	1l5qB-2zt9A: undetectable	1l5qB-2zt9A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.02A	1l7xA-2zt9A: undetectable	1l7xA-2zt9A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.06A	1l7xB-2zt9A: undetectable	1l7xB-2zt9A: 13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P33_D_MTXD354_1 (PTERIDINE REDUCTASE 1)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	5 / 12	SER A 91 PRO B 77 TYR B 80 LEU A 138 TYR A 183	None None None HEM A 301 ( 4.2A) None	1.50A	1p33D-2zt9A: undetectable	1p33D-2zt9A: 20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YAJ_G_BEZG3385_0 (CES1 PROTEIN)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 8 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	3 / 3	SER H 10 VAL B 56 LEU B 57	None	0.56A	1yajG-2zt9H: undetectable	1yajG-2zt9H: 4.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BDM_A_TMIA501_1 (CYTOCHROME P450 2B4)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 5 CYTOCHROME B6-F COMPLEX SUBUNIT 7 (Nostoc sp. PCC 7120)	4 / 7	LEU F 10 PHE F 13 GLY G 12 ILE B 145	None	0.92A	2bdmA-2zt9F: undetectable	2bdmA-2zt9F: 6.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OMB_A_IPHA2001_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	4 / 5	HIS B 24 PRO A 214 TYR B 27 PRO B 7	None	1.50A	2ombA-2zt9B: undetectable 2ombB-2zt9B: undetectable	2ombA-2zt9B: 19.81 2ombB-2zt9B: 19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEU_A_ACTA142_0 (PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE)	2zt9	CYTOCHROME B6 (Nostoc sp. PCC 7120)	4 / 5	GLU A 156 PRO A 155 ILE A 165 GLY A 162	None	1.15A	2qeuA-2zt9A: undetectable 2qeuC-2zt9A: undetectable	2qeuA-2zt9A: 20.83 2qeuC-2zt9A: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEU_B_ACTB141_0 (PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	3 / 3	PRO A 28 ASN G 33 ARG G 31	None	0.97A	2qeuB-2zt9A: undetectable	2qeuB-2zt9A: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VL2_A_BEZA1162_0 (PEROXIREDOXIN-5)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	5 / 10	PRO B 7 PRO A 27 GLY B 28 LEU B 18 GLY B 23	None	1.44A	2vl2A-2zt9B: undetectable 2vl2C-2zt9B: undetectable	2vl2A-2zt9B: 22.11 2vl2C-2zt9B: 22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9S_D_TOPD1158_1 (DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	5 / 10	ILE B 51 ALA B 53 LEU A 81 ILE A 85 PHE B 48	None	1.14A	2w9sD-2zt9B: undetectable	2w9sD-2zt9B: 23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W9S_F_TOPF1159_1 (DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	5 / 10	ILE B 51 ALA B 53 LEU A 81 ILE A 85 PHE B 48	None	1.13A	2w9sF-2zt9B: undetectable	2w9sF-2zt9B: 23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2I_B_QPSB1050_2 (ALPHA-1,4-GLUCAN LYASE ISOZYME 1)	2zt9	CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1 (Nostoc sp. PCC 7120)	4 / 6	TYR D 133 TRP D 177 TRP D 178 THR D 89	None	1.46A	2x2iB-2zt9D: undetectable	2x2iB-2zt9D: 10.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BCR_A_AZZA940_1 (GLYCOGEN PHOSPHORYLASE, MUSCLE FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 5	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.00A	3bcrA-2zt9A: undetectable	3bcrA-2zt9A: 13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.02A	3dd1A-2zt9A: undetectable	3dd1A-2zt9A: 13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.03A	3dd1B-2zt9A: undetectable	3dd1B-2zt9A: 13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.03A	3ddsA-2zt9A: undetectable	3ddsA-2zt9A: 13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.03A	3ddsB-2zt9A: undetectable	3ddsB-2zt9A: 13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.02A	3ddwA-2zt9A: undetectable	3ddwA-2zt9A: 13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120)	4 / 6	ASN A 31 ALA G 24 GLY G 20 TYR G 23	None None BCR G 101 (-3.4A) BCR G 101 (-3.7A)	1.01A	3ddwB-2zt9A: undetectable	3ddwB-2zt9A: 13.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_C_CHDC151_0 (ILEAL BILE ACID-BINDING PROTEIN)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 8 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	5 / 10	ILE B 44 VAL A 42 GLY A 38 VAL H 22 LEU B 36	None None HEM A 303 ( 3.4A) None None	1.10A	3elzC-2zt9B: undetectable	3elzC-2zt9B: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM0_A_CHDA151_0 (ILEAL BILE ACID-BINDING PROTEIN)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 8 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	5 / 10	ILE B 44 VAL A 42 GLY A 38 VAL H 22 LEU B 36	None None HEM A 303 ( 3.4A) None None	1.11A	3em0A-2zt9B: undetectable	3em0A-2zt9B: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HCO_A_CHDA4_0 (FERROCHELATASE, MITOCHONDRIAL)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	5 / 9	MET A 96 LEU G 13 SER A 89 VAL B 43 GLY B 46	OPC H 30 ( 3.9A) BCR G 101 ( 4.0A) None BCR G 101 ( 3.9A) BCR G 101 ( 4.7A)	1.41A	3hcoA-2zt9A: undetectable	3hcoA-2zt9A: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HCO_B_CHDB924_0 (FERROCHELATASE, MITOCHONDRIAL)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	5 / 10	MET A 96 LEU G 13 SER A 89 VAL B 43 GLY B 46	OPC H 30 ( 3.9A) BCR G 101 ( 4.0A) None BCR G 101 ( 3.9A) BCR G 101 ( 4.7A)	1.42A	3hcoB-2zt9A: undetectable	3hcoB-2zt9A: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HCP_B_CHDB4_0 (FERROCHELATASE, MITOCHONDRIAL)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 5 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	3 / 3	GLY B 23 PRO B 7 LEU G 35	None	0.61A	3hcpB-2zt9B: undetectable	3hcpB-2zt9B: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MBG_A_ACTA500_0 (FAD-LINKED SULFHYDRYL OXIDASE ALR)	2zt9	CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1 (Nostoc sp. PCC 7120)	4 / 4	ALA D 144 HIS D 110 HIS D 129 PRO D 143	FES D 200 ( 4.8A) FES D 200 (-3.2A) FES D 200 (-3.0A) FES D 200 ( 4.5A)	1.25A	3mbgA-2zt9D: undetectable	3mbgA-2zt9D: 19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MBG_C_ACTC900_0 (FAD-LINKED SULFHYDRYL OXIDASE ALR)	2zt9	CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1 (Nostoc sp. PCC 7120)	4 / 4	ALA D 144 HIS D 110 HIS D 129 PRO D 143	FES D 200 ( 4.8A) FES D 200 (-3.2A) FES D 200 (-3.0A) FES D 200 ( 4.5A)	1.25A	3mbgC-2zt9D: undetectable	3mbgC-2zt9D: 19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_A_AICA375_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 5 CYTOCHROME B6-F COMPLEX SUBUNIT 7 (Nostoc sp. PCC 7120)	5 / 11	GLY G 8 LEU F 10 SER F 12 LEU F 6 LEU F 5	None None OPC H 30 (-4.8A) None None	1.18A	3ndvA-2zt9G: undetectable 3ndvB-2zt9G: undetectable	3ndvA-2zt9G: 9.84 3ndvB-2zt9G: 9.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_B_AICB376_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 5 CYTOCHROME B6-F COMPLEX SUBUNIT 7 (Nostoc sp. PCC 7120)	5 / 11	LEU F 6 LEU F 5 GLY G 8 LEU F 10 SER F 12	None None None None OPC H 30 (-4.8A)	1.15A	3ndvA-2zt9F: undetectable 3ndvB-2zt9F: undetectable	3ndvA-2zt9F: 7.78 3ndvB-2zt9F: 7.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_C_AICC375_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 5 CYTOCHROME B6-F COMPLEX SUBUNIT 7 (Nostoc sp. PCC 7120)	5 / 11	GLY G 8 LEU F 10 SER F 12 LEU F 6 LEU F 5	None None OPC H 30 (-4.8A) None None	1.15A	3ndvC-2zt9G: undetectable 3ndvD-2zt9G: undetectable	3ndvC-2zt9G: 9.84 3ndvD-2zt9G: 9.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_D_AICD374_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 5 CYTOCHROME B6-F COMPLEX SUBUNIT 7 (Nostoc sp. PCC 7120)	5 / 11	LEU F 6 LEU F 5 GLY G 8 LEU F 10 SER F 12	None None None None OPC H 30 (-4.8A)	1.16A	3ndvC-2zt9F: undetectable 3ndvD-2zt9F: undetectable	3ndvC-2zt9F: 7.78 3ndvD-2zt9F: 7.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F8Y_C_VK3C202_1 (NADPH QUINONE OXIDOREDUCTASE)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	4 / 7	ARG A 87 TYR B 80 LEU B 81 TYR A 183	HEM A 301 (-3.6A) None None None	1.13A	4f8yC-2zt9A: undetectable 4f8yD-2zt9A: undetectable	4f8yC-2zt9A: 22.62 4f8yD-2zt9A: 22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	4 / 7	VAL A 151 ALA A 147 LEU A 169 LEU B 81	None	0.82A	4l9iA-2zt9A: 2.5	4l9iA-2zt9A: 17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QZU_B_ACTB202_0 (RETINOL-BINDING PROTEIN 2)	2zt9	CYTOCHROME B6 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	4 / 7	TYR A 136 TYR B 82 LEU B 76 TRP B 79	None	1.40A	4qzuB-2zt9A: 0.0	4qzuB-2zt9A: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RJD_B_TFPB204_1 (CALMODULIN)	2zt9	CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1 CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	4 / 8	LEU D 32 GLY D 33 MET B 45 ALA B 49	None	0.90A	4rjdA-2zt9D: undetectable 4rjdB-2zt9D: undetectable	4rjdA-2zt9D: 18.06 4rjdB-2zt9D: 18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_G_377G401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	4 / 6	TYR B 82 ARG B 89 GLU B 74 LEU B 149	None	1.15A	4twdF-2zt9B: undetectable 4twdG-2zt9B: undetectable	4twdF-2zt9B: 19.22 4twdG-2zt9B: 19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UBE_A_2FAA401_2 (ADENOSINE KINASE)	2zt9	CYTOCHROME B6 (Nostoc sp. PCC 7120)	4 / 4	ALA A 125 VAL A 101 GLY A 37 THR A 40	HEM A 302 ( 3.8A) HEM A 302 (-4.1A) HEM A 302 (-3.3A) HEM A 302 (-4.2A)	1.10A	4ubeA-2zt9A: undetectable	4ubeA-2zt9A: 22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE8_A_08JA602_1 (CYTOCHROME P450 3A4)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 (Nostoc sp. PCC 7120)	4 / 7	SER B 90 LEU B 155 ILE B 145 LEU B 157	None	0.88A	5te8A-2zt9B: undetectable	5te8A-2zt9B: 17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AG0_A_ACRA605_0 (ALPHA-AMYLASE)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 8 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	4 / 8	TYR B 38 GLY H 25 ASP B 35 PRO B 30	None None HEM A 303 ( 4.6A) None	0.78A	6ag0A-2zt9B: undetectable	6ag0A-2zt9B: 23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AG0_C_ACRC605_0 (ALPHA-AMYLASE)	2zt9	CYTOCHROME B6-F COMPLEX SUBUNIT 4 CYTOCHROME B6-F COMPLEX SUBUNIT 8 (Nostoc sp. PCC 7120; Nostoc sp. PCC 7120)	4 / 8	TYR B 38 GLY H 25 ASP B 35 PRO B 30	None None HEM A 303 ( 4.6A) None	0.82A	6ag0C-2zt9B: undetectable	6ag0C-2zt9B: 23.12

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C8L_A_CFFA940_1","PROTEIN (GLYCOGEN PHOSPHORYLASE)","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.00A","1c8lA-2zt9A:undetectable","1c8lA-2zt9A:13.32"],["1DVT_A_FLPA125_1","TRANSTHYRETIN;TRANSTHYRETIN","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",4,"LEU B 149;LEU B  96;LEU B  91;SER B  90","None","0.98A","1dvtA-2zt9B:undetectable;1dvtB-2zt9B:undetectable","1dvtA-2zt9B:23.31;1dvtB-2zt9B:23.31"],["1GFZ_A_CFFA940_1","GLYCOGEN PHOSPHORYLASE","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.01A","1gfzA-2zt9A:undetectable","1gfzA-2zt9A:13.32"],["1L5Q_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.04A","1l5qA-2zt9A:undetectable","1l5qA-2zt9A:13.86"],["1L5Q_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.03A","1l5qB-2zt9A:undetectable","1l5qB-2zt9A:13.86"],["1L7X_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.02A","1l7xA-2zt9A:undetectable","1l7xA-2zt9A:13.86"],["1L7X_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.06A","1l7xB-2zt9A:undetectable","1l7xB-2zt9A:13.86"],["1P33_D_MTXD354_1","PTERIDINE REDUCTASE 1","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",5,"SER A  91;PRO B  77;TYR B  80;LEU A 138;TYR A 183","None;None;None;HEM A 301 ( 4.2A);None","1.50A","1p33D-2zt9A:undetectable","1p33D-2zt9A:20.49"],["1YAJ_G_BEZG3385_0","CES1 PROTEIN","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 8","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",3,"SER H  10;VAL B  56;LEU B  57","None","0.56A","1yajG-2zt9H:undetectable","1yajG-2zt9H:4.87"],["2BDM_A_TMIA501_1","CYTOCHROME P450 2B4","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 5;CYTOCHROME B6-F COMPLEX SUBUNIT 7","Nostoc sp. PCC 7120",4,"LEU F  10;PHE F  13;GLY G  12;ILE B 145","None","0.92A","2bdmA-2zt9F:undetectable","2bdmA-2zt9F:6.90"],["2OMB_A_IPHA2001_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",4,"HIS B  24;PRO A 214;TYR B  27;PRO B   7","None","1.50A","2ombA-2zt9B:undetectable;2ombB-2zt9B:undetectable","2ombA-2zt9B:19.81;2ombB-2zt9B:19.81"],["2QEU_A_ACTA142_0","PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE","2zt9","CYTOCHROME B6","Nostoc sp. PCC 7120",4,"GLU A 156;PRO A 155;ILE A 165;GLY A 162","None","1.15A","2qeuA-2zt9A:undetectable;2qeuC-2zt9A:undetectable","2qeuA-2zt9A:20.83;2qeuC-2zt9A:20.83"],["2QEU_B_ACTB141_0","PUTATIVE CARBOXYMUCONOLACTONE DECARBOXYLASE","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",3,"PRO A  28;ASN G  33;ARG G  31","None","0.97A","2qeuB-2zt9A:undetectable","2qeuB-2zt9A:20.83"],["2VL2_A_BEZA1162_0","PEROXIREDOXIN-5","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",5,"PRO B   7;PRO A  27;GLY B  28;LEU B  18;GLY B  23","None","1.44A","2vl2A-2zt9B:undetectable;2vl2C-2zt9B:undetectable","2vl2A-2zt9B:22.11;2vl2C-2zt9B:22.11"],["2W9S_D_TOPD1158_1","DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",5,"ILE B  51;ALA B  53;LEU A  81;ILE A  85;PHE B  48","None","1.14A","2w9sD-2zt9B:undetectable","2w9sD-2zt9B:23.63"],["2W9S_F_TOPF1159_1","DIHYDROFOLATE REDUCTASE TYPE 1 FROM TN4003","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",5,"ILE B  51;ALA B  53;LEU A  81;ILE A  85;PHE B  48","None","1.13A","2w9sF-2zt9B:undetectable","2w9sF-2zt9B:23.63"],["2X2I_B_QPSB1050_2","ALPHA-1,4-GLUCAN LYASE ISOZYME 1","2zt9","CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1","Nostoc sp. PCC 7120",4,"TYR D 133;TRP D 177;TRP D 178;THR D  89","None","1.46A","2x2iB-2zt9D:undetectable","2x2iB-2zt9D:10.73"],["3BCR_A_AZZA940_1","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.00A","3bcrA-2zt9A:undetectable","3bcrA-2zt9A:13.32"],["3DD1_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.02A","3dd1A-2zt9A:undetectable","3dd1A-2zt9A:13.72"],["3DD1_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.03A","3dd1B-2zt9A:undetectable","3dd1B-2zt9A:13.72"],["3DDS_A_CFFA904_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.03A","3ddsA-2zt9A:undetectable","3ddsA-2zt9A:13.72"],["3DDS_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.03A","3ddsB-2zt9A:undetectable","3ddsB-2zt9A:13.72"],["3DDW_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.02A","3ddwA-2zt9A:undetectable","3ddwA-2zt9A:13.72"],["3DDW_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120",4,"ASN A  31;ALA G  24;GLY G  20;TYR G  23","None;None;BCR G 101 (-3.4A);BCR G 101 (-3.7A)","1.01A","3ddwB-2zt9A:undetectable","3ddwB-2zt9A:13.72"],["3ELZ_C_CHDC151_0","ILEAL BILE ACID-BINDING PROTEIN","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 8","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",5,"ILE B  44;VAL A  42;GLY A  38;VAL H  22;LEU B  36","None;None;HEM A 303 ( 3.4A);None;None","1.10A","3elzC-2zt9B:undetectable","3elzC-2zt9B:21.89"],["3EM0_A_CHDA151_0","ILEAL BILE ACID-BINDING PROTEIN","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 8","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",5,"ILE B  44;VAL A  42;GLY A  38;VAL H  22;LEU B  36","None;None;HEM A 303 ( 3.4A);None;None","1.11A","3em0A-2zt9B:undetectable","3em0A-2zt9B:21.89"],["3HCO_A_CHDA4_0","FERROCHELATASE, MITOCHONDRIAL","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",5,"MET A  96;LEU G  13;SER A  89;VAL B  43;GLY B  46","OPC H  30 ( 3.9A);BCR G 101 ( 4.0A);None;BCR G 101 ( 3.9A);BCR G 101 ( 4.7A)","1.41A","3hcoA-2zt9A:undetectable","3hcoA-2zt9A:19.89"],["3HCO_B_CHDB924_0","FERROCHELATASE, MITOCHONDRIAL","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",5,"MET A  96;LEU G  13;SER A  89;VAL B  43;GLY B  46","OPC H  30 ( 3.9A);BCR G 101 ( 4.0A);None;BCR G 101 ( 3.9A);BCR G 101 ( 4.7A)","1.42A","3hcoB-2zt9A:undetectable","3hcoB-2zt9A:19.89"],["3HCP_B_CHDB4_0","FERROCHELATASE, MITOCHONDRIAL","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 5","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",3,"GLY B  23;PRO B   7;LEU G  35","None","0.61A","3hcpB-2zt9B:undetectable","3hcpB-2zt9B:19.31"],["3MBG_A_ACTA500_0","FAD-LINKED SULFHYDRYL OXIDASE ALR","2zt9","CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1","Nostoc sp. PCC 7120",4,"ALA D 144;HIS D 110;HIS D 129;PRO D 143","FES D 200 ( 4.8A);FES D 200 (-3.2A);FES D 200 (-3.0A);FES D 200 ( 4.5A)","1.25A","3mbgA-2zt9D:undetectable","3mbgA-2zt9D:19.79"],["3MBG_C_ACTC900_0","FAD-LINKED SULFHYDRYL OXIDASE ALR","2zt9","CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1","Nostoc sp. PCC 7120",4,"ALA D 144;HIS D 110;HIS D 129;PRO D 143","FES D 200 ( 4.8A);FES D 200 (-3.2A);FES D 200 (-3.0A);FES D 200 ( 4.5A)","1.25A","3mbgC-2zt9D:undetectable","3mbgC-2zt9D:19.79"],["3NDV_A_AICA375_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 5;CYTOCHROME B6-F COMPLEX SUBUNIT 7","Nostoc sp. PCC 7120",5,"GLY G   8;LEU F  10;SER F  12;LEU F   6;LEU F   5","None;None;OPC H  30 (-4.8A);None;None","1.18A","3ndvA-2zt9G:undetectable;3ndvB-2zt9G:undetectable","3ndvA-2zt9G:9.84;3ndvB-2zt9G:9.84"],["3NDV_B_AICB376_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 5;CYTOCHROME B6-F COMPLEX SUBUNIT 7","Nostoc sp. PCC 7120",5,"LEU F   6;LEU F   5;GLY G   8;LEU F  10;SER F  12","None;None;None;None;OPC H  30 (-4.8A)","1.15A","3ndvA-2zt9F:undetectable;3ndvB-2zt9F:undetectable","3ndvA-2zt9F:7.78;3ndvB-2zt9F:7.78"],["3NDV_C_AICC375_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 5;CYTOCHROME B6-F COMPLEX SUBUNIT 7","Nostoc sp. PCC 7120",5,"GLY G   8;LEU F  10;SER F  12;LEU F   6;LEU F   5","None;None;OPC H  30 (-4.8A);None;None","1.15A","3ndvC-2zt9G:undetectable;3ndvD-2zt9G:undetectable","3ndvC-2zt9G:9.84;3ndvD-2zt9G:9.84"],["3NDV_D_AICD374_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 5;CYTOCHROME B6-F COMPLEX SUBUNIT 7","Nostoc sp. PCC 7120",5,"LEU F   6;LEU F   5;GLY G   8;LEU F  10;SER F  12","None;None;None;None;OPC H  30 (-4.8A)","1.16A","3ndvC-2zt9F:undetectable;3ndvD-2zt9F:undetectable","3ndvC-2zt9F:7.78;3ndvD-2zt9F:7.78"],["4F8Y_C_VK3C202_1","NADPH QUINONE OXIDOREDUCTASE;NADPH QUINONE OXIDOREDUCTASE","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",4,"ARG A  87;TYR B  80;LEU B  81;TYR A 183","HEM A 301 (-3.6A);None;None;None","1.13A","4f8yC-2zt9A:undetectable;4f8yD-2zt9A:undetectable","4f8yC-2zt9A:22.62;4f8yD-2zt9A:22.62"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",4,"VAL A 151;ALA A 147;LEU A 169;LEU B  81","None","0.82A","4l9iA-2zt9A:2.5","4l9iA-2zt9A:17.17"],["4QZU_B_ACTB202_0","RETINOL-BINDING PROTEIN 2","2zt9","CYTOCHROME B6;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",4,"TYR A 136;TYR B  82;LEU B  76;TRP B  79","None","1.40A","4qzuB-2zt9A:0.0","4qzuB-2zt9A:19.63"],["4RJD_B_TFPB204_1","CALMODULIN;CALMODULIN","2zt9","CYTOCHROME B6-F COMPLEX IRON-SULFUR SUBUNIT 1;CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",4,"LEU D  32;GLY D  33;MET B  45;ALA B  49","None","0.90A","4rjdA-2zt9D:undetectable;4rjdB-2zt9D:undetectable","4rjdA-2zt9D:18.06;4rjdB-2zt9D:18.06"],["4TWD_G_377G401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",4,"TYR B  82;ARG B  89;GLU B  74;LEU B 149","None","1.15A","4twdF-2zt9B:undetectable;4twdG-2zt9B:undetectable","4twdF-2zt9B:19.22;4twdG-2zt9B:19.22"],["4UBE_A_2FAA401_2","ADENOSINE KINASE","2zt9","CYTOCHROME B6","Nostoc sp. PCC 7120",4,"ALA A 125;VAL A 101;GLY A  37;THR A  40","HEM A 302 ( 3.8A);HEM A 302 (-4.1A);HEM A 302 (-3.3A);HEM A 302 (-4.2A)","1.10A","4ubeA-2zt9A:undetectable","4ubeA-2zt9A:22.09"],["5TE8_A_08JA602_1","CYTOCHROME P450 3A4","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4","Nostoc sp. PCC 7120",4,"SER B  90;LEU B 155;ILE B 145;LEU B 157","None","0.88A","5te8A-2zt9B:undetectable","5te8A-2zt9B:17.03"],["6AG0_A_ACRA605_0","ALPHA-AMYLASE","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 8","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",4,"TYR B  38;GLY H  25;ASP B  35;PRO B  30","None;None;HEM A 303 ( 4.6A);None","0.78A","6ag0A-2zt9B:undetectable","6ag0A-2zt9B:23.12"],["6AG0_C_ACRC605_0","ALPHA-AMYLASE","2zt9","CYTOCHROME B6-F COMPLEX SUBUNIT 4;CYTOCHROME B6-F COMPLEX SUBUNIT 8","Nostoc sp. PCC 7120;Nostoc sp. PCC 7120",4,"TYR B  38;GLY H  25;ASP B  35;PRO B  30","None;None;HEM A 303 ( 4.6A);None","0.82A","6ag0C-2zt9B:undetectable","6ag0C-2zt9B:23.12"]]